C4 Therapeutics CCCC
NASDAQ CCCC
$3.01 -0.13 (-4.14%)
As of: Oct 2, 2026 · 3:24 PM EDT

C4 Therapeutics (CCCC) Selling, General & Administrative (2019 - 2026)

Updated

C4 Therapeutics (CCCC) reported Selling, General & Administrative of $8.59 million for Q2 2026, down 2.0% from $8.77 million a year earlier and down 7.9% from the prior quarter.

Analysis

C4 Therapeutics (CCCC) Selling, General & Administrative (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, C4 Therapeutics' Selling, General & Administrative came in at $36.02 million, down 10.5% year-over-year; for FY2025, it was $36.2 million, down 14.1% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of 18.9% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $42.12 million in FY2024 (+0.1%), $42.08 million in FY2023 (-1.7%), $42.79 million in FY2022 (+28.7%) and $33.25 million in FY2021 (+118.7%).
  • The Q2 2026 figure ranks as the lowest quarterly Selling, General & Administrative since Q3 2021.
  • Year over year, Selling, General & Administrative gained in two of the last eight quarters, with an average decline of 5.5%.
  • The high point for year-over-year Selling, General & Administrative in five years was Q3 2021 (growth of 195.4%); the low point was Q3 2025 (a decline of 24.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $9.33 million (Q1 2026), $9.18 million (Q4 2025) and $8.92 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.43 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.63 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -5.65 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.92 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 582.20 Mn
10 C4 Therapeutics 409.28 Mn -520.48 Mn - 8.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.59 Mn
Mar 31, 2026 9.33 Mn
Dec 31, 2025 9.18 Mn
Sep 30, 2025 8.92 Mn
Jun 30, 2025 8.77 Mn
Mar 31, 2025 9.33 Mn
Dec 31, 2024 10.37 Mn
Sep 30, 2024 11.77 Mn
Jun 30, 2024 9.70 Mn
Mar 31, 2024 10.29 Mn
Dec 31, 2023 10.30 Mn
Sep 30, 2023 10.53 Mn
Jun 30, 2023 10.31 Mn
Mar 31, 2023 10.95 Mn
Dec 31, 2022 10.50 Mn
Sep 30, 2022 9.58 Mn
Jun 30, 2022 9.90 Mn
Mar 31, 2022 12.82 Mn
Dec 31, 2021 8.78 Mn
Sep 30, 2021 8.45 Mn
API Access

C4 Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CCCC&period=max&api_key=YOUR_API_KEY